Altruistic punishment in patients with Parkinson's disease with and without impulsive behaviour

Neuropsychologia

Volumn 49, Issue 1, 2011, Pages 103-107

  Djamshidian, Atbin ^b   O'Sullivan, Sean S ^b   Doherty, Karen ^b   Lees, Andrew J ^b   Averbeck, Bruno B ^a,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Altruistic punishment; Dopaminergic medication; Impulsive compulsive behaviour; Parkinson's disease

Indexed keywords

DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

ADULT; ALTRUISM; ARTICLE; COMPULSION; CONTROLLED STUDY; DECISION MAKING; DISEASE DURATION; DOPAMINERGIC ACTIVITY; FEMALE; HUMAN; HYPERSEXUALITY; IMPULSIVENESS; INVESTMENT; KLEPTOMANIA; MALE; ONSET AGE; PARKINSON DISEASE; PATHOLOGICAL GAMBLING; PUNISHMENT; SHOPPING; TASK PERFORMANCE;

AGED; ALTRUISM; ANALYSIS OF VARIANCE; FEMALE; HUMANS; IMPULSIVE BEHAVIOR; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PUNISHMENT;

EID: 78650214491     PISSN: 00283932     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropsychologia.2010.10.012     Document Type: Article

References (37)

1. Abe N., Fujii T., Hirayama K., Takeda A., Hosokai Y., Ishioka T., et al. Do parkinsonian patients have trouble telling lies? The neurobiological basis of deceptive behaviour. Brain 2009, 132:1386-1395.
2. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2000, American Psychiatric Association, Washington, DC. 4th ed., text rev.
3. Bodi N., Keri S., Nagy H., Moustafa A., Myers C.E., Daw N., et al. Reward-learning and the novelty-seeking personality: A between- and within-subjects study of the effects of dopamine agonists on young Parkinson's patients. Brain 2009, 132:2385-2395.
4. Boyd R., Gintis H., Bowles S. Coordinated punishment of defectors sustains cooperation and can proliferate when rare. Science 2010, 328:617-620.
5. Brewer J.A., Potenza M.N. The neurobiology and genetics of impulse control disorders: Relationships to drug addictions. Biochemical Pharmacology 2008, 75:63-75.
6. Cools R., Barker R.A., Sahakian B.J., Robbins T.W. Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. Cerebral Cortex 2001, 11:1136-1143.
7. Crockett, M., Clark, L., Liebermann, M., Tabibnia, G., & Robbins, T. (in press). Impulsive choice and altruistic punishment are correlated and increase in tandem with serotonin depletion. Emotion.
8. de Quervain D.J., Fischbacher U., Treyer V., Schellhammer M., Schnyder U., Buck A., et al. The neural basis of altruistic punishment. Science 2004, 305:1254-1258.
9. Djamshidian A., Jha A., O'Sullivan S.S., Silveira-Moriyama L., Jacobson C., Brown P., et al. Risk and learning in impulsive and nonimpulsive patients with Parkinson's disease. Movement Disorders 2010, 25(October (13)):2203-2210.
10. Evans A.H., Katzenschlager R., Paviour D., O'Sullivan J.D., Appel S., Lawrence A.D., et al. Punding in Parkinson's disease: Its relation to the dopamine dysregulation syndrome. Movement Disorders 2004, 19:397-405.
11. Evans A.H., Lawrence A.D., Cresswell S.A., Katzenschlager R., Lees A.J. Compulsive use of dopaminergic drug therapy in Parkinson's disease: Reward and anti-reward. Movement Disorders 2010, 25:867-876.
12. Evans A.H., Lawrence A.D., Potts J., MacGregor L., Katzenschlager R., Shaw K., et al. Relationship between impulsive sensation seeking traits, smoking, alcohol and caffeine intake, and Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry 2006, 77:317-321.
13. Fehr E., Gachter S. Altruistic punishment in humans. Nature 2002, 415:137-140.
14. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state" A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975, 12:189-198.
15. Frank M.J., Seeberger L.C., O'Reilly R.C. By carrot or by stick: Cognitive reinforcement learning in parkinsonism. Science 2004, 306:1940-1943.
16. Gibb W.R., Lees A.J. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry 1988, 51:745-752.
17. Haber S.N., Kim K.S., Mailly P., Calzavara R. Reward-related cortical inputs define a large striatal region in primates that interface with associative cortical connections, providing a substrate for incentive-based learning. The Journal of Neuroscience 2006, 26:8368-8376.
18. Ishihara L., Bayne C. What is the evidence for a premorbid parkinsonian personality: A systematic review. Movement Disorders 2006, 21(8):1066-1072.
19. King-Casas B., Tomlin D., Anen C., Camerer C.F., Quartz S.R., Montague P.R. Getting to know you: Reputation and trust in a two-person economic exchange. Science 2005, 308:78-83.
20. Lawrence A.D., Evans A.H., Lees A.J. Compulsive use of dopamine replacement therapy in Parkinson's disease: Reward systems gone awry?. Lancet Neurology 2003, 2:595-604.
21. Lim S.Y., Evans A.H., Miyasaki J.M. Impulse control and related disorders in Parkinson's disease: Review. Annals of the New York Academy of Sciences 2008, 1142:85-107.
22. McElroy S.L., Keck P.E., Pope H.G., Smith J.M., Strakowski S.M. Compulsive buying: A report of 20 cases. The Journal of Clinical Psychiatry 1994, 55:242-248.
23. Menza M. The personality associated with Parkinson's disease. Current Psychiatry Reports 2000, 2:421-426.
24. O'Sullivan S.S., Evans A.H., Lees A.J. Dopamine dysregulation syndrome: An overview of its epidemiology, mechanisms and management. CNS Drugs 2009, 23:157-170.
25. Potenza M.N., Voon V., Weintraub D. Drug Insight: Impulse control disorders and dopamine therapies in Parkinson's disease. Nature Clinical Practice. Neurology 2007, 3:664-672.
26. Prick J. Genuine parkinsonism. A psychosomatic, anthropological-psychiatric approach. Abs World Congress of Psychiatry Madrid 1966.
27. Rutledge R.B., Lazzaro S.C., Lau B., Myers C.E., Gluck M.A., Glimcher P.W. Dopaminergic drugs modulate learning rates and perseveration in Parkinson's patients in a dynamic foraging task. The Journal of Neuroscience 2009, 29:15104-15114.
28. Sanfey A.G., Rilling J.K., Aronson J.A., Nystrom L.E., Cohen J.D. The neural basis of economic decision-making in the Ultimatum Game. Science 2003, 300:1755-1758.
29. Sigmund K. Punish or perish? Retaliation and collaboration among humans. Trends in Ecology & Evolution 2007, 22:593-600.
30. Todes C.J., Lees A.J. The pre-morbid personality of patients with Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry 1985, 48:97-100.
31. Voon V., Hassan K., Zurowski M., de Souza M., Thomsen T., Fox S., et al. Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology 2006, 67:1254-1257.
32. Voon V., Hassan K., Zurowski M., Duff-Canning S., de Souza M., Fox S., et al. Prospective prevalence of pathologic gambling and medication association in Parkinson disease. Neurology 2006, 66:1750-1752.
33. Voon V., Pessiglione M., Brezing C., Gallea C., Fernandez H.H., Dolan R.J., et al. Mechanisms underlying dopamine-mediated reward bias in compulsive behaviors. Neuron 2010, 65:135-142.
34. Voon V., Reynolds B., Brezing C., Gallea C., Skaljic M., Ekanayake V., et al. Impulsive choice and response in dopamine agonist-related impulse control behaviors. Psychopharmacology 2009, (Berl).
35. Voon V., Thomsen T., Miyasaki J.M., de Souza M., Shafro A., Fox S.H., et al. Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease. Archives of Neurology 2007, 64:212-216.
36. Weintraub D., Potenza M.N. Impulse control disorders in Parkinson's disease. Current Neurology and Neuroscience Reports 2006, 6:302-306.
37. Weintraub D., Siderowf A.D., Potenza M.N., Goveas J., Morales K.H., Duda J.E., et al. Association of dopamine agonist use with impulse control disorders in Parkinson disease. Archives of Neurology 2006, 63:969-973.